logo BDSP

Base documentaire

  1. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mital regurgitant murmur.

    Article - En anglais

    To assess the cost-effectiveness of prevention of infective endocarditis (IE) and to calculate cost-effectiveness of currently recommended regimens in patients with mitral valve prolapse (MVP), data on risk of death, complications, and health-care use, and cumulative incremental health-care costs due to the occurrence of IE were combined with data on the prevalence and manifestations of MVP, estimated years of life lost, in efficacy of antibiotic prophylaxis.

    Effectiveness and costs of standard endocarditis prophylaxis regimens were calculated per IE case prevented and years of life saved.

    Mots-clés Pascal : Prolapsus, Valvule mitrale, Régurgitation, Endocardite, Bactériose, Infection, Prévention, Chimiothérapie, Antibiotique, Coût, Homme, Appareil circulatoire pathologie, Cardiopathie valvulaire, Cardiopathie, Endocarde pathologie

    Mots-clés Pascal anglais : Prolapsus, Mitral valve, Regurgitation, Endocarditis, Bacteriosis, Infection, Prevention, Chemotherapy, Antibiotic, Costs, Human, Cardiovascular disease, Cardiac valvular disease, Heart disease, Endocardial disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0071816

    Code Inist : 002B05B02D. Création : 09/06/1995.